Skip to content

Post-market Registry in Patients With Iliac Aneurysm Undergoing Endovascular Stenting With the E-liac Stent Graft System

PLIANT - A Post-market Registry in Patients With Iliac Aneurysm Undergoing Endovascular Stenting With a New Generation of Low Profile E-liac Stent Graft System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02209194
Enrollment
47
Registered
2014-08-05
Start date
2014-06-30
Completion date
2019-09-30
Last updated
2020-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iliac Aneurysm

Keywords

aneurysms, vascular disease, E-liac Stent Graft, E-liac Stent Graft System, iliac aneurysm, branched stent graft, self expanding stent graft

Brief summary

The purpose of the study is to evaluate the clinical and technical success as well as safety and feasibility of the E-liac Stent Graft System used in endovascular treatment of uni- or bilateral aortoiliac or iliac aneurysm. Main study target is the exclusion of aneurysm with primary patency of the arteria iliaca interna and the arteria iliaca externa on iliac implantation side.

Interventions

DEVICEE-liac Stent Graft System

Implantation of the E-liac Stent Graft System in combination with a peripheral covered stent and in case of aortoiliac aneurysm in combination with a AAA Stent Graft

Sponsors

JOTEC GmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must comply with the indications for use * Unilateral or bilateral common iliac aneurysm diameter equal or greater 25mm * Unsuitable distal sealing site within the common iliac artery for traditional EVAR

Exclusion criteria

* Patients with a stenotic internal iliac ostium of \< 4mm in diameter * Patients with severe internal iliac atherosclerosis * Patients that do not have a suitable landing area in the main stem of the IIA * Patients with pseudoaneurysms * Patients with symptomatic and ruptured iliac aneurysms * Patients with one of the contraindications as indicated in the instructions for use * Patients pretreated with a bifurcated vascular graft * Patient with thrombocytopenia * Patient with creatinine \>2.4 mg/dl immediately before the intervention * Patient with malignancy needing chemotherapy or radiation * Patients who are enrolled in another clinical study * Patients with life expectancy of less than 36 months

Design outcomes

Primary

MeasureTime frameDescription
Primary patencywithin 30 daysPrimary patency of the arteria iliaca interna and the arteria iliaca externa on E-liac implantation side
Primary Patency12 months
Endoleak Type I or IIIwithin 30 days

Secondary

MeasureTime frame
Stent graft dislodgement36 months
Distal embolization36 months
Stent graft kinking36 months
Rate of complications36 months
Rate of death36 months
Change in aneurysm sizewithin 30 days (baseline) and 36 months
Stent graft migrationwithin 30 days (baseline) and 36 months

Countries

Austria, Germany, Poland, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026